Marco Benedetti, currently corporate controller and principal accounting officer, will transition to the role of vice president responsible for financial planning & analysis and investor relations functions for the company.
Dr. Kaiser will immediately assume the company’s newly-created CTO position, where he will serve as the leader of QiG Group – Greatbatch’s research and development subsidiary – and also provide strategic guidance and technical leadership to the Greatbatch Medical and Electrochem businesses.
Since joining Greatbatch in 2008, Dr. Kaiser has taken on increasing responsibility in a number of key leadership roles in product planning, marketing, and development. His most recent role included leading the product development, design assurance, and regulatory affairs for QiG Group’s Cardiovascular Portfolio. Prior to joining Greatbatch, he held positions of progressive responsibility within established medical device companies such as Medtronic, Inc. and Guidant Corporation, led the research efforts of a large Cardiology private practice at the St. Paul Heart Clinic, and fostered research and innovation at the academic level with over 23 publications as an adjunct assistant professor at the University of Minnesota. Dr. Kaiser, who received a Bachelors of Science in Electrical Engineering from the University of Wisconsin – Madison, and a MS and Ph.D. in Biophysical Sciences and Medical Physics from the University of Minnesota, is the inventor or co-inventor of 10 granted and pending patents.“Dan has demonstrated exceptional performance in navigating our cardiovascular portfolio, including spearheading five product approvals. His leadership of QiG Group will be essential as we drive the commercialization phase of our medical device and systems strategy,” said Mr. Hook. QiG Group was previously led by Mr. Hook, under whose leadership it has grown to more than 150 highly skilled research and development Associates. About Greatbatch Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to industries that depend on reliable, long-lasting performance through its brands Greatbatch Medical, Electrochem and QiG Group. Greatbatch Medical develops and manufactures critical medical device technologies for the cardiac, neurology, vascular and orthopaedic markets. Electrochem designs and manufactures battery and wireless sensing technologies for high-end niche applications in the energy, military, portable medical, and other markets. The QiG Group empowers the design and development of new medical devices for our core markets. Additional information about the Company is available at www.greatbatch.com.